Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Human embryonic stem cell–derived cardiomyocytes (hESC-CMs) to treat ischemia/reperfusion injury. Science-Business eXchange 7, 628 (2014). https://doi.org/10.1038/scibx.2014.628
Issue Date:
DOI: https://doi.org/10.1038/scibx.2014.628